polyanionic dendrimer derivatives (Utah/BRI)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepolyanionic dendrimer derivatives (Utah/BRI)
Drug Alias NameBRI-2792BRI-6149BR-2992BR-6157BRI-2993 +[8] 
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUtah State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUtah State UniversityBiomolecular Research Institute
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A